Menu
About Us
Overview
Board
Team
Corporate Directory
Our Science
Gene Silencing
Intellectual Property
Partnering
Our Programs
Areas of Research
Pipeline
Out-Licensed Programs
Presentations and Publications
For Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Contact Us
Presentations
Investors
Investors
Overview
News & Events
Overview
Press Releases
Events
Media Coverage
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Annual Reports
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Jan 5, 2023
Corporate Presentation, January 2023
Jun 27, 2022
Corporate Presentation, June 2022
Sep 8, 2021
Corporate Presentation, September 2021
Feb 24, 2021
Interim Results of IND-Enabling Large Animal Study for BB-301
Sep 13, 2020
Corporate Presentation, September 2020
Apr 11, 2020
Corporate Presentation, April 2020
Nov 29, 2019
Chairman’s Presentation to Shareholders
Sep 26, 2019
Corporate Presentation, September 2019
Sep 24, 2019
Ladenburg Thalmann Healthcare Conference Presentation
Nov 11, 2018
AASLD Presentation
1
2
Next
Email Alerts
Contacts
RSS News Feed